⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3507651 | 0.74 | CSNK2A2 (0.43) | — | |
| SCHEMBL2032749 | 0.74 | CSNK2A2 (0.43) | — | |
| SCHEMBL1729905 | 0.65 | KMT2A (0.38) | — | |
| SCHEMBL1564214 | 0.63 | KMT2A (0.53) | — | |
| SCHEMBL57078 | 0.63 | KMT2A (0.53) | — | |
| SCHEMBL10609538 | 0.63 | KMT2A (0.53) | — | |
| SCHEMBL24220960 | 0.60 | SLC6A9 (0.40) | — | |
| SCHEMBL1133814 | 0.60 | — | — | |
| SCHEMBL15387071 | 0.60 | — | — | |
| SCHEMBL1165366 | 0.60 | SLC6A9 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2229935-A1 | Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition | Nebolsin, Vladimir Evgenievich (RU) | 2010-09-22 | — | — | EP | claimed |
| EP-1981629-A1 | IPBC-CONTAINING COACERVATES | Lanxess Deutschland GmbH (DE) | 2008-10-22 | — | — | EP | claimed |
| WO-2007087994-A1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-08-09 | — | — | WO | claimed |
| EP-1020179-A2 | PEPTIDE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PRODUCING THE SAME, USE OF SAID DERIVATIVES AND PHARMACEUTICAL COMPOSITION | Nebolsin, Vladimir Evgenievich (RU) | 2000-07-19 | — | — | EP | claimed |